MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Combining intraoperative microelectrode recordings with postoperative transcranial B-mode sonography of the brainstem to estimate the anatomical position of the electrode for chronic subthalamic nucleus deep brain stimulation in Parkinson´s disease

    R. Reese, T. Kriesen, M. Kersten, A. Storch, M. Löhle, U. Walter (Rostock, Germany)

    Objective: We tested whether the position of the electrode for deep brain stimulation (DBS) could be assessed relative to subthalamic nucleus (STN) dorsal boundaries by…
  • 2022 International Congress

    Spinal cord stimulation for gait problems in Parkinson´s disease: Long term report and placebo viability

    R. Carra, J. Menezes, T. Capato, K. Duarte, R. Cury (Sao Paulo, Brazil)

    Objective: In the present study we set out to report a very long-term follow-up period of spinal cord stimulation (SCS) for Parkinson's Disease (PD) patients…
  • 2022 International Congress

    Knowledge and attitude of Egyptian general public towards Parkinson disease: A cross-sectional study in Egypt.

    M. Alwerdani, A. Hassanin, A. Ashour, A. Khalil, R. Elbayar, M. Doheim, N. Elsaid, A. Shalash (Cairo, Egypt)

    Objective: We aim to investigate the public Egyptian knowledge and attitude towards PD. Background: In Egypt, the PD prevalence reached 316.50 per 100,000 people. Given…
  • 2022 International Congress

    Psychometric characteristics of the Neuropsychiatric Fluctuation Scale

    E. Schmitt, B. Debu, A. Kistner, A. Castrioto, V. Fraix, M. Bouvard, E. Moro (grenoble, France)

    Objective: To evaluate the psychometric properties of the Neuropsychiatric fluctuation scale (NFS) for Parkinson’s disease (PD). Background: Neuropsychiatric fluctuations (NpsyF) in PD are frequent and…
  • 2022 International Congress

    Quality of life and patient reported outcomes with subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 BeyoND study

    W. Poewe, F. Stocchi, L. Adar, T. Yardeni, A. Espay (Innsbruck, Austria)

    Objective: To review quality of life and other patient reported outcomes data from the ND0612 BeyoND study. Background: ND0612 is in development as a continuous,…
  • 2022 International Congress

    Impact of istradefylline on the adjustment of levodopa dose escalation in Parkinson’s disease: Results of the ISTRA ADJUST PD randomized, controlled study

    T. Hatano, O. Kano, R. Sengoku, N. Yanagisawa, H. Nagayama (Tokyo, Japan)

    Objective: To evaluate the effect of istradefylline (IST), an adenosine A2A receptor antagonist, on the adjustment of levodopa dose escalation in patients with Parkinson’s disease…
  • 2022 International Congress

    Computer vision can detect changes in bradykinesia associated with dopaminergic state in Parkinson’s disease

    JF. Martín-Rodríguez, S. Camba Fernandez, D. Rodriguez Gordo, S. Garcia-Ojeda, B. Benitez Zamora, L. Muñoz-Delgado, F. Carrillo, P. Mir (Sevilla, Spain)

    Objective: To evaluate the classification accuracy of a computer vision-based feature extraction and classifier method to detect changes in finger tap bradykinesia associated with dopaminergic…
  • 2022 International Congress

    A case with clinical features of alpha-synuclein- and tauopathy: Genetic and histopathological workup.

    D. Gruber, C. Mawrin, A. Vogel, T. Usnich, N. Brueggemann, C. Klein, P. Bauer, F. Gandor, G. Ebersbach (Beelitz-Heilstaetten, Germany)

    Objective: Here, we present a clinical case that mimicked the coincidence of idiopathic Parkinson’s disease (PD) and tauopathy. Background: Mutation in leucine-rich-repeat-kinase 2 (LRRK2) gene…
  • 2022 International Congress

    Multimodal mechanistic disease stratification in sporadic Parkinson’s disease

    T. Payne, T. Burgess, M. Sassani, S. Roscoe, S. Bradley, A. Anton, E. Reed, I. Wilkinson, H. Mortiboys, T. Jenkins, O. Bandmann (Sheffield, United Kingdom)

    Objective: To mechanistically stratify Parkinson’s disease (PD), applying a combination of putaminal 31Phosphorus magnetic resonance spectroscopy (31P-MRS) with detailed assessment of mitochondrial and lysosomal function…
  • 2022 International Congress

    Concomitant Medication Use and Levodopa Equivalent Daily Dose Requirements After Foslevodopa/foscarbidopa Initiation

    D. Santos Garcia, L. Bergmann, B. Bergmans, F. Bergquist, S. Criswell, V. Fung, J. Jia, P. Kukreja, N. Pavasia, W. Robieson, Z. Zhang, D. Standaert (A Coruña, Spain)

    Objective: To evaluate patterns of concomitant medication use and levodopa equivalent daily dose (LEDD) during a 52 week study with foslevodopa/foscarbidopa (LDP/CDP). Background: LDP/CDP is…
  • « Previous Page
  • 1
  • …
  • 457
  • 458
  • 459
  • 460
  • 461
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley